| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-10 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-09 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-07 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.19 | 0.002 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.17 | 0.005 |